• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

Sufentanil (citrate)

(CAS: 60561-17-3)

Suppliers of Sufentanil (citrate)

Company Name Email Tel Country
Carbosynth Limited [email protected] +44 (1635) 578-444

Fax: +44 (1635) 579-444Purity: Brand:

Price and Availability: USD150/5mg ()

Cayman Chemical Company [email protected] Toll Free (USA and Canada Only): (800) 364-9897; Direct: (734) 971-3335;Technical Support Toll Free (USA and Canada Only): (888) 526-5351;Technical Support Direct: (734) 975-3888 USA

Fax: (734) 971-3640Purity: Brand:

Sigma-Aldrich, Inc. [email protected] +86 (21) 6141-5566 / 800-819-3336 USA

Fax: Purity: Brand:

Price and Availability: USD156/5mg ()

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:
Remarks:
 

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of Sufentanil (citrate)

Sufentanil citrate(R30730) is a powerful synthetic mu-opioid receptor agonist, approximately 5 to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine. IC50 value: Target: mu-opioid receptor Sufentanil, an opioid analgesic, is an analogue of fentanyl, and has been used for the induction and maintenance of anaesthesia, and for postsurgical analgesia.

Solubility of Sufentanil (citrate)

Solubility Sources

Storage Condition of Sufentanil (citrate)

Storage Condition Sources

MSDS Information

MSDS Sources

Quality Control and Spectral Data

QC Reports Sources

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Sufentanil (citrate) University Hospital, Toulouse Anaesthetic Induction 2013/7/15 2013/7/01 Phase 3 Clinical
Sufentanil (citrate) Aarhus University Hospital Ischaemic Heart Disease Aortic Stenosis 2014/1/06 2015/8/01 Phase 3 Clinical
Sufentanil (citrate) University of Sao Paulo Postoperative Pain 2012/7/02 2015/5/01 Phase 3 Clinical
Sufentanil (citrate) Islamic Azad University, Tehran Irreversible Pulpitis 2012/3/03 2012/4/01 Phase 2 Clinical
Sufentanil (citrate) University of Erlangen-Nürnberg Medical School Pain 2011/11/28 2014/12/01 Phase 3 Clinical
Sufentanil (citrate) - Launched

Chemical Information

M.Wt Formula CAS No. Synonyms
578.67 C28H38N2O9S 60561-17-3 R30730 citrate;Sufentanyl citrate;Sufenta citrate; N-(4-(methoxymethyl)-1-(2-(thiophen-2-yl)ethyl)piperidin-4-yl)-N-phenylpropionamide 2-hydroxypropane-1,2,3-tricarboxylate

Structure Information of Sufentanil (citrate)

Smiles O=C(CC(C(O)=O)(O)CC(O)=O)O.CCC(N(C1(COC)CCN(CCC2=CC=CS2)CC1)C3=CC=CC=C3)=O
InChI InChI=1S/C22H30N2O2S.C6H8O7/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h4-10,17H,3,11-16,18H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

Related Products

Other Form Products of Sufentanil (citrate)

Name CAS Formula Suppliers
Sufentanil 56030-54-7 C22H30N2O2S 5

Recommended Products in Same Target

Name CAS Formula Suppliers
Eluxadoline 864821-90-9 C32H35N5O5 8
Buprenorphine (hydrochloride) 53152-21-9 C29H42ClNO4 6
Oxymorphone 76-41-5 C17H19NO4 2
TRV130 1401028-24-7 C22H30N2O2S 6
Loperamide (hydrochloride) 34552-83-5 C29H34Cl2N2O2 18
Trimebutine 39133-31-8 C22H29NO5 13
Meptazinol (hydrochloride) 59263-76-2 C15H24ClNO 12
Alvimopan (dihydrate) 170098-38-1 C25H36N2O6 14
LY2795050 1346133-08-1 C23H22ClN3O2 8
Spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine, 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenyl-, cis- (9CI) 863513-93-3 C24H27FN2O 3
Matrine 519-02-8 C15H24N2O 29
Naloxone (hydrochloride) 357-08-4 C19H22ClNO4 17
Sufentanil 56030-54-7 C22H30N2O2S 5
Cebranopadol 863513-91-1 C24H27FN2O 12
Methylnaltrexone (Bromide) 73232-52-7 C21H26BrNO4 12
Tapentadol 175591-23-8 C14H23NO 3
Tapentadol (hydrochloride) 175591-09-0 C14H24ClNO 11
Naltrexone 16590-41-3 C20H23NO4 7
Naltrexone (Hydrochloride) 16676-29-2 C20H24ClNO4 16
Alvimopan (monohydrate) 1383577-62-5 C25H34N2O5 8

Recommended Products in the Same Indication

Name CAS Formula Suppliers
Tropisetron 89565-68-4 C17H20N2O2 11
Capsaicin 404-86-4 C18H27NO3 15
Etodolac 41340-25-4 C17H21NO3 27
Sufentanil 56030-54-7 C22H30N2O2S 5
PH-797804 586379-66-0 C22H19BrF2N2O3 13
Cebranopadol 863513-91-1 C24H27FN2O 12
Gabapentin (hydrochloride) 60142-95-2 C9H18ClNO2 12
ADL-5859 850173-95-4 C24H29ClN2O3 13
Gabapentin 60142-96-3 C9H17NO2 33
Nepafenac 78281-72-8 C15H14N2O2 26
Celecoxib 169590-42-5 C17H14F3N3O2S 17
Atomoxetine (hydrochloride) 82248-59-7 C17H22ClNO 29
Diazepam 439-14-5 C16H13ClN2O 7
Naloxone (hydrochloride) 357-08-4 C19H22ClNO4 17
Etoricoxib 202409-33-4 C18H15ClN2O2S 17
Pregabalin 148553-50-8 C8H17NO2 28
Rofecoxib 162011-90-7 C17H14O4S 17
Tapentadol (hydrochloride) 175591-09-0 C14H24ClNO 11
(S)-3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole 1252673-29-2 C22H26N2O2S 9
Valdecoxib 181695-72-7 C16H14N2O3S 23

Safety Data of Sufentanil (citrate)

Hazard Symbols:T+,T,F Risk Statements:26/27/28-39/23/24/25-23/24/25-11 Safety Statements:26-27-28-36/37/39-45-36/37-16-7
Transport Information: HS Code: RTECS:
WGK Germany:

Chemical and Physical Properties

Appearance:Light yellow to yellow Solid Melting point:96.60C
Boiling point: Flash Point:
Water Solubility: Solubility:
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:262-295-4
Optical Rotation: alpha:

Tags: buy Sufentanil (citrate) | Sufentanil (citrate) IC50 | Sufentanil (citrate) price | Sufentanil (citrate) cost | Sufentanil (citrate) solubility | Sufentanil (citrate) purchase | Sufentanil (citrate) manufacturer | Sufentanil (citrate) research buy | Sufentanil (citrate) order | Sufentanil (citrate) MSDS | Sufentanil (citrate) chemical structure | Sufentanil (citrate) Storage condition | Sufentanil (citrate) molecular weight | Sufentanil (citrate) mw | Sufentanil (citrate) datasheet | Sufentanil (citrate) supplier | Sufentanil (citrate) cell line | Sufentanil (citrate) NMR | Sufentanil (citrate) MS | Sufentanil (citrate) IR | Sufentanil (citrate) solubility | Sufentanil (citrate) Safe information | Sufentanil (citrate) Qc and Spectral Information | Sufentanil (citrate) Clinical Information | Sufentanil (citrate) Clinical Trial | Sufentanil (citrate) Route of Synthesis | Sufentanil (citrate) storage condition | Sufentanil (citrate) diseases and conditions | Sufentanil (citrate) flash point | Sufentanil (citrate) boiling point | Sufentanil (citrate) melting point | Sufentanil (citrate) storage condition | Sufentanil (citrate) brand